246 related articles for article (PubMed ID: 10430621)
21. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S
Gut; 2002 Nov; 51(5):677-84. PubMed ID: 12377806
[TBL] [Abstract][Full Text] [Related]
22. Defects of DNA mismatch repair in human prostate cancer.
Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
[TBL] [Abstract][Full Text] [Related]
23. Mismatch repair proteins MSH2, MLH1, and EXO1 are important for class-switch recombination events occurring in B cells that lack nonhomologous end joining.
Eccleston J; Yan C; Yuan K; Alt FW; Selsing E
J Immunol; 2011 Feb; 186(4):2336-43. PubMed ID: 21242524
[TBL] [Abstract][Full Text] [Related]
24. Class switch recombination efficiency and junction microhomology patterns in Msh2-, Mlh1-, and Exo1-deficient mice depend on the presence of mu switch region tandem repeats.
Eccleston J; Schrader CE; Yuan K; Stavnezer J; Selsing E
J Immunol; 2009 Jul; 183(2):1222-8. PubMed ID: 19553545
[TBL] [Abstract][Full Text] [Related]
25. Ig isotype switching in B lymphocytes. Isolation and characterization of clonal variants of the murine Ly-1+ B cell lymphoma, CH12, expressing isotypes other than IgM.
Arnold LW; Grdina TA; Whitmore AC; Haughton G
J Immunol; 1988 Jun; 140(12):4355-63. PubMed ID: 3131432
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulin class switch recombination is impaired in Atm-deficient mice.
Lumsden JM; McCarty T; Petiniot LK; Shen R; Barlow C; Wynn TA; Morse HC; Gearhart PJ; Wynshaw-Boris A; Max EE; Hodes RJ
J Exp Med; 2004 Nov; 200(9):1111-21. PubMed ID: 15504820
[TBL] [Abstract][Full Text] [Related]
27. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation.
Ehrenstein MR; Neuberger MS
EMBO J; 1999 Jun; 18(12):3484-90. PubMed ID: 10369687
[TBL] [Abstract][Full Text] [Related]
28. Elevated mutant frequencies and increased C : G-->T : A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells.
Baross-Francis A; Makhani N; Liskay RM; Jirik FR
Oncogene; 2001 Feb; 20(5):619-25. PubMed ID: 11313994
[TBL] [Abstract][Full Text] [Related]
29. Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.
Wu X; Platt JL; Cascalho M
Mol Cell Biol; 2003 May; 23(9):3320-8. PubMed ID: 12697830
[TBL] [Abstract][Full Text] [Related]
30. Biallelic somatic inactivation of the mismatch repair gene MLH1 in a primary skin melanoma.
Castiglia D; Pagani E; Alvino E; Vernole P; Marra G; Cannavò E; Jiricny J; Zambruno G; D'Atri S
Genes Chromosomes Cancer; 2003 Jun; 37(2):165-75. PubMed ID: 12696065
[TBL] [Abstract][Full Text] [Related]
31. Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination.
Ehrenstein MR; Rada C; Jones AM; Milstein C; Neuberger MS
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14553-8. PubMed ID: 11717399
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.
Cannavo E; Gerrits B; Marra G; Schlapbach R; Jiricny J
J Biol Chem; 2007 Feb; 282(5):2976-86. PubMed ID: 17148452
[TBL] [Abstract][Full Text] [Related]
33. Visualization of mosaicism in tissues of normal and mismatch-repair-deficient mice carrying a microsatellite-containing transgene.
Hersh MN; Stambrook PJ; Stringer JR
Mutat Res; 2002 Aug; 505(1-2):51-62. PubMed ID: 12175905
[TBL] [Abstract][Full Text] [Related]
34. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
[TBL] [Abstract][Full Text] [Related]
35. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.
Buchanan DD; Tan YY; Walsh MD; Clendenning M; Metcalf AM; Ferguson K; Arnold ST; Thompson BA; Lose FA; Parsons MT; Walters RJ; Pearson SA; Cummings M; Oehler MK; Blomfield PB; Quinn MA; Kirk JA; Stewart CJ; Obermair A; Young JP; Webb PM; Spurdle AB
J Clin Oncol; 2014 Jan; 32(2):90-100. PubMed ID: 24323032
[TBL] [Abstract][Full Text] [Related]
36. Loss of DNA-mismatch repair gene expression in oral melanomas.
Korabiowska M; Brinck U; Ruschenburg I; Honig JF; Stachura J; Droese M
Oncol Rep; 1999; 6(4):921-3. PubMed ID: 10373682
[TBL] [Abstract][Full Text] [Related]
37. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A
Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438
[TBL] [Abstract][Full Text] [Related]
38. DNA mismatch repair enzyme activity and gene expression in prostate cancer.
Yeh CC; Lee C; Dahiya R
Biochem Biophys Res Commun; 2001 Jul; 285(2):409-13. PubMed ID: 11444857
[TBL] [Abstract][Full Text] [Related]
39. Postreplicative mismatch repair factors are recruited to Epstein-Barr virus replication compartments.
Daikoku T; Kudoh A; Sugaya Y; Iwahori S; Shirata N; Isomura H; Tsurumi T
J Biol Chem; 2006 Apr; 281(16):11422-30. PubMed ID: 16510450
[TBL] [Abstract][Full Text] [Related]
40. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
Jessup CJ; Redston M; Tilton E; Reimann JD
Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
